Track the Bruker Cellular Analysis, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 3 October 2023 (J). Among the most active insiders: BRUKER CORP. The full history is free.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bruker Cellular Analysis, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,708 of 28,932 companies
34.5
score / 100
Value
23
Quality
46
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn68%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.